KOMAR INTIMATES, LLC – Trademark Portfolio

Entity Type: 16

KOMAR INTIMATES, LLC holds 38 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 37 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 8 trademarks are registered and 1 is pending. Notable registered marks include TISHA, DREAMFIT, DREAM FIT, LE MYSTERE, and LE MYSTÈRE. The owner is based in NEW YORK, NY.

16 EAST 34TH STREET

NEW YORK, NY 10016

38 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (38 results)

Trademark Classifications

KOMAR INTIMATES, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (37 filings)

Clothing, footwear, headgear

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does KOMAR INTIMATES, LLC have?

KOMAR INTIMATES, LLC has 38 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 5 abandoned, 24 cancelled.

What trademark classes does KOMAR INTIMATES, LLC file in?

KOMAR INTIMATES, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 3 (Cosmetics & Cleaning). Class 25 covers clothing, footwear, headgear.

What are KOMAR INTIMATES, LLC's most well-known trademarks?

KOMAR INTIMATES, LLC's registered trademark portfolio includes well-known marks such as TISHA, DREAMFIT, DREAM FIT, LE MYSTERE, and LE MYSTÈRE. These are among 8 currently registered trademarks in the portfolio.

What is KOMAR INTIMATES, LLC's trademark registration success rate?

KOMAR INTIMATES, LLC has a 22% trademark registration rate, with 8 out of 37 resolved applications resulting in successful registration. Currently, 1 application is pending review.